Increase compliance with comprehensive literature coverage from key biomedical databases required by regulatory and other key bodies. Our content experts and engineers add 750,000 items to the system every day and standardise the formats produced. This permits you to have up-to-date content that feeds easily into your pharmacovigilance workflow. You can choose our end-to-end suite of content, software and services tailored for drug safety monitoring and reporting, or adopt any of them separately. Most of the top 10 global pharmaceutical companies use our products, as well as multiple small and medium-sized biopharma, medical device and contract research organisations.
Increase patient safety with truly comprehensive content coverage using standardised, deduplicated biomedical content required by the regulators including Medline, Embase, IPA, Biosis, Derwent Drug File conference databases and many more. With over 100 databases available, searches for signal evaluations are also supported.
Dialog’s precision search is optimized for pharmacovigilance and is proven to minimize the volume of duplicated references delivered into the review process. Dialog outputs native XML enabling content to be integrated seamlessly into your Drug Safety Ecosystem.
The Dialog Alerts Manager makes the setup, maintenance and management of alerts an easy and time-efficient activity. Pharmacovigilance searches can be scheduled run automatically on a day and time of your choosing and deliver the results directly to the Drug Safety Triager.
After the references have been reviewed, those containing patient safety issues can be automatically output to seamlessly integrate with your existing Drug Safety Ecosystem.
Validated and compliant
Reduce risk in your literature monitoring process with a fully automated workflow, and manage all incoming literature consistently, creating a systematic literature review process, with added functionality, that is fully validated and compliant